Inhibiting acetate metabolism shows promise in breast cancer model
Drug Target Review,
Inhibiting the ACSS2 enzyme with a molecule called VY-3-135 caused a significant reduction in the growth of breast cancer…
Inhibiting the ACSS2 enzyme with a molecule called VY-3-135 caused a significant reduction in the growth of breast cancer…
New small molecule inhibitor impairs cancer growth in preclinical models by depriving malignant cells of a critical nutrient…
New small molecule inhibitor impairs cancer growth in preclinical models by depriving malignant cells of a critical nutrient…
Newswise — PHILADELPHIA — (Jan. 7, 2021) — Scientists at The characterized an inhibitor that targets acetate metabolism in…
Post Views: 6 PHILADELPHIA (Jan. 7, 2021) Scientists at The Wistar Institute characterized an inhibitor that targets acetate…
PHILADELPHIA — (Jan. 7, 2021) — Scientists at The characterized an inhibitor that targets acetate metabolism in cancer cells.
PHILADELPHIA -- (Jan. 7, 2021) -- Scientists at The Wistar Institute characterized an inhibitor that targets acetate metabolism…